Literature DB >> 22722924

P53 protein profile by IHC may be helpful to define patient prognosis.

Marjory Alana Marcello, Elaine Cristina Morari, Laura Sterian Ward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22722924     DOI： 10.1007/s12032-012-0282-0

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  2 in total

1.  A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the Surveillance, Epidemiology, and End Results (SEER) registry.

Authors:  Hop S Tran Cao; Lily E Johnston; David C Chang; Michael Bouvet
Journal:  Surgery       Date:  2012-04-11       Impact factor: 3.982

2.  Prognostic value of oncoprotein expressions in thyroid papillary carcinoma.

Authors:  A Z Balta; A I Filiz; Y Kurt; I Sucullu; E Yucel; M L Akin
Journal:  Med Oncol       Date:  2011-05-06       Impact factor: 3.064
  2 in total
  2 in total

1.  THE ASSOCIATION BETWEEN LYMPH NODE METASTASIS AND MOLECULAR MARKERS IN DIFFERENTIATED THYROID CANCER.

Authors:  B I Aydoğan; C C Ersöz; S D Sak; S Güllü
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jan-Mar       Impact factor: 0.877

2.  P53 and expression of immunological markers may identify early stage thyroid tumors.

Authors:  Marjory Alana Marcello; Elaine Cristina Morari; Lucas Leite Cunha; Aline Carolina De Nadai Silva; Dirce Maria Carraro; André Lopes Carvalho; Fernando Augusto Soares; José Vassallo; Laura Sterian Ward
Journal:  Clin Dev Immunol       Date:  2013-09-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.